ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RXRX Recursion Pharmaceuticals Inc

7.64
0.15 (2.00%)
Last Updated: 18:29:46
Delayed by 15 minutes
Share Name Share Symbol Market Type
Recursion Pharmaceuticals Inc NASDAQ:RXRX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 2.00% 7.64 7.64 7.65 7.71 7.14 7.24 10,559,494 18:29:46

Recursion to Present at 43rd Annual JP Morgan Healthcare Conference

06/01/2025 1:30pm

GlobeNewswire Inc.


Recursion Pharmaceuticals (NASDAQ:RXRX)
Historical Stock Chart


From Dec 2024 to Jan 2025

Click Here for more Recursion Pharmaceuticals Charts.

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that co-founder and CEO Chris Gibson, PhD will present at the upcoming 43rd Annual JP Morgan Healthcare Conference in San Francisco.

On Monday, January 13, 7:30am PT (10:30am ET), at the Westin St. Francis in the Elizabethan Room A/B, Dr. Gibson will present updates on Recursion’s latest clinical pipeline, partnerships, and platform following the company’s recent combination with Exscientia. The talk will be available on Recursion’s website for at least 30 days following the presentation here: https://ir.recursion.com/news-events/events-presentations. 

Ryan Kelly
Recursion Pharmaceuticals
media@recursion.com

1 Year Recursion Pharmaceuticals Chart

1 Year Recursion Pharmaceuticals Chart

1 Month Recursion Pharmaceuticals Chart

1 Month Recursion Pharmaceuticals Chart